Product Information

CIMETIDINE 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2304 per EA under NDC 59651082401. Its NADAC has been published 68 times since May 7, 2025.

FDA first approved this application on Nov 12, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CIMETIDINE 300 MG TABLET

CIMETIDINE
$0.2304per EA

Strength

300 mg/1

NDC

59651082401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CIMETIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA218997

FDA Approved

11/12/2024

TE Code

AB

On Market Since

11/12/2024

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price Statistics

The NADAC for CIMETIDINE 300 MG TABLET has been published 68 times since May 7, 2025, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2304 per EA
All-time high$0.2899 (Jun 11, 2025)
All-time low$0.2265 (Jul 22, 2026)
52-week high$0.2779
52-week low$0.2265
Median price$0.2605
Average price$0.2621
Largest weekly change-5.7% (May 20, 2026)
Weeks tracked68
Tracking sinceMay 7, 2025

Price History

1W

+1.7%

1M

+1.7%

3M

-3.2%

6M

-11.5%

1Y

-17.1%

3Y

N/A

5Y

N/A

All

-19.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CIMETIDINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2304 per EA (NDC 59651082401), effective Aug 19, 2026.

How has the price of CIMETIDINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for CIMETIDINE 300 MG TABLET has declined 19.0%. It has been tracked across 68 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for CIMETIDINE 300 MG TABLET?

Since May 7, 2025, the NADAC for CIMETIDINE 300 MG TABLET has ranged from a low of $0.2265 (Jul 22, 2026) to a high of $0.2899 (Jun 11, 2025), with a median of $0.2605 per EA.

Are there cheaper alternatives to CIMETIDINE 300 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIMETIDINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CIMETIDINE 300 MG TABLET?

CIMETIDINE 300 MG TABLET (NDC 59651082401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.